| Date | Form | Description | Docs | XBRL | Pages |
| 06/19/13 | 10-Q/A | Quarterly report pursuant to sections 13 or 15(d) |
|
|
3 |
| 06/14/13 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
2 | |
| 06/14/13 | EFFECT | Notice of Effectiveness |
|
1 | |
| 06/14/13 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
66 | |
| 06/14/13 | S-1/A | General form of registration statement for all companies including face-amount certificate companies |
|
16 | |
| 06/11/13 | UPLOAD | SEC-generated letter |
|
1 | |
| 05/28/13 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
6 | |
| 05/22/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/21/13 | UPLOAD | SEC-generated letter |
|
3 | |
| 05/21/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization
Read More...Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s
Read More...Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025
Read More...